NFG
AMPE

Next Financial Group’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Next Financial Group’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-67
Closed -$18K – 2375
2016
Q4 		$18K Hold
67
– – ﹤0.01% 1421
2016
Q3 		$15K Buy
+67
New +$18.8K ﹤0.01% 1496
2014
Q4 		– Sell
-47
Closed -$49K – 2434
2014
Q3 		$49K Hold
47
– – 0.01% 956
2014
Q2 		$90K Buy
+47
New +$95.9K 0.05% 246

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
FPCP
Fort Point Capital Partners San Francisco, California $825M AUM 16.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Next Financial Group's AMPE Position: Q1 2017 in Review

Next Financial Group sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2017, closing a stake of 67 shares — an estimated $18K sold.

Next Financial Group first reported a position in AMPE in Q2 2014 and held it in 4 quarters. The position peaked at $90K in Q2 2014. 64 funds tracked by Wall St. Rank hold AMPE as of Q1 2017.

  • Next Financial Group reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2017 after selling out during the quarter.
  • Next Financial Group sold 67 Ampio Pharmaceuticals Inc. shares in Q1 2017, an estimated $18K.
  • Next Financial Group first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 4 quarters.
  • Next Financial Group's Ampio Pharmaceuticals Inc. position peaked at $90K in Q2 2014.
  • 64 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2017.

Based on Next Financial Group's 13F filing for Q1 2017, filed 8 May 2017.